INSIGHTS ON CLINICAL TRIAL DESIGN
-
Proving CNS Target Engagement With Neuroimaging In Early Clinical Drug Development
The key question is not whether a scan changes, but what link in the dose-to-effect chain it resolves. Combining PET, MRI, PK/PD, and functional measures reduces uncertainty.
-
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
Factors Affecting Systemic Drug Exposure
The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.
-
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials
Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
-
Why You Should Include SDOH In Clinical Trial Recruitment1/28/2025
Embrace a broader approach to diversity in clinical trials by addressing social determinants of health and designing inclusive studies that ensure equitable representation and access to all patients.
-
Making Early Decisions In Psychiatric Drug Development7/30/2026
Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric
-
Addressing Trial Design Hurdles Across Alzheimer's Disease Stages12/10/2025
Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
-
Advancing Clinical Research In 2025: Meeting FDA Standards In DCT1/22/2025
Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.
-
No More Back And Forth: Building eCOAs Right The First Time5/27/2025
Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.
-
A structured data lifecycle from protocol design to database lock keeps trial data clean, compliant, and ready for regulatory submission.
-
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
-
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.